|
|
|
Insider
Information: |
Thompson Tommy G |
Relationship: |
Director |
City: |
Saint Louis |
State: |
MO |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
10 |
|
Direct
Shares |
2,385,169 |
|
Indirect Shares
|
5,118,253 |
|
|
Direct
Value |
$23,352,883 |
|
|
Indirect Value
|
$15,778,516 |
|
|
Total
Shares |
7,503,422 |
|
|
Total
Value |
$39,131,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
3
|
Stock
price went up :
|
1
|
3
|
Stock
price went down : |
4
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
Percentage
Gain/Loss : |
-26.9%
|
104.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Centene Corp |
CNC |
Director |
2021-12-31 |
227,334 |
2021-12-31 |
160,896 |
Premium* |
|
CR Bard Inc |
BCR |
Director |
2017-12-29 |
0 |
2005-10-03 |
0 |
Premium* |
|
Pure Bioscience |
PURE |
Director |
2009-07-01 |
589,537 |
2007-05-23 |
0 |
Premium* |
|
United Therapeutics Corp |
UTHR |
|
2024-03-11 |
8,480 |
2024-03-08 |
14,000 |
Premium* |
|
Careview Communications Inc |
CRVW |
Director |
2012-12-26 |
1,325,222 |
2013-04-01 |
4,845,424 |
Premium* |
|
Plus Therapeutics Inc |
PSTV |
Director |
2015-05-08 |
103,986 |
2015-09-03 |
83,600 |
Premium* |
|
Therapeuticsmd Inc |
TXMD |
Director |
2022-08-18 |
5,954 |
2022-08-18 |
14,333 |
Premium* |
|
Physicians Realty Trust |
DOC |
Director |
2024-03-01 |
0 |
2024-03-01 |
0 |
Premium* |
|
Vyant Bio Ord Shs |
VYNT |
Director |
2013-10-10 |
2,500 |
2013-10-10 |
0 |
Premium* |
|
Healthpeak Properties |
PEAK |
Director |
2024-04-26 |
122,156 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
284 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 11 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PURE |
Pure Bioscience |
Director |
|
2009-01-07 |
4 |
S |
$3.40 |
$51,060 |
D/D |
(15,000) |
602,800 |
0 |
- |
|
CNC |
Centene Corp |
Director |
|
2015-03-13 |
4 |
AS |
$65.36 |
$1,045,760 |
D/D |
(16,000) |
170,307 |
0 |
- |
|
CNC |
Centene Corp |
Director |
|
2015-03-13 |
4 |
OE |
$13.37 |
$213,920 |
D/D |
16,000 |
186,307 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2019-03-18 |
4 |
OE |
$52.65 |
$900,315 |
D/D |
17,100 |
20,070 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-03-25 |
4 |
S |
$5.06 |
$88,550 |
D/D |
(17,500) |
216,100 |
0 |
- |
|
DOC |
Physicians Realty Trust |
Director |
|
2022-12-13 |
4 |
B |
$15.16 |
$269,242 |
I/I |
17,760 |
19,060 |
2.1 |
% |
|
PURE |
Pure Bioscience |
Director |
|
2008-02-01 |
4 |
S |
$5.41 |
$100,076 |
D/D |
(18,500) |
80,000 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-01-22 |
4 |
S |
$5.28 |
$105,670 |
D/D |
(20,000) |
105,000 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-07-25 |
4 |
S |
$5.15 |
$103,000 |
D/D |
(20,000) |
358,000 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2009-01-08 |
4 |
S |
$3.29 |
$65,700 |
D/D |
(20,000) |
602,800 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2009-01-09 |
4 |
S |
$3.32 |
$66,476 |
D/D |
(20,000) |
572,837 |
0 |
- |
|
CRVW |
Careview Communications I... |
Director |
|
2013-04-01 |
4 |
B |
$0.50 |
$10,000 |
I/I |
20,202 |
4,845,424 |
2.1 |
- |
|
PSTV |
Plus Therapeutics Inc |
Director |
|
2011-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
21,000 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2009-05-14 |
4 |
A |
$2.34 |
$50,778 |
D/D |
21,700 |
594,537 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-04-01 |
4 |
S |
$5.99 |
$149,645 |
D/D |
(25,000) |
191,100 |
0 |
- |
|
PSTV |
Plus Therapeutics Inc |
Director |
|
2015-09-03 |
4 |
B |
$0.37 |
$9,531 |
I/I |
25,449 |
83,600 |
2.1 |
- |
|
DOC |
Physicians Realty Trust |
Director |
|
2024-03-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(25,635) |
0 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2007-05-23 |
4 |
A |
$3.00 |
$90,000 |
D/D |
30,000 |
30,000 |
0 |
- |
|
PURE |
Pure Bioscience |
Director |
|
2008-04-09 |
4 |
A |
$5.70 |
$171,000 |
D/D |
30,000 |
211,100 |
0 |
- |
|
TXMD |
Therapeuticsmd Inc |
Chairman |
|
2013-03-14 |
4 |
B |
$1.70 |
$51,000 |
I/I |
30,000 |
630,000 |
2.1 |
- |
|
PSTV |
Plus Therapeutics Inc |
Director |
|
2015-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
42,785 |
42,785 |
0 |
- |
|
CNC |
Centene Corp |
Director |
|
2020-11-06 |
4 |
GA |
$0.00 |
$0 |
I/I |
60,000 |
60,000 |
0 |
- |
|
CNC |
Centene Corp |
Director |
|
2020-11-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
60,000 |
26,896 |
0 |
- |
|
CNC |
Centene Corp |
Director |
|
2020-10-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
74,000 |
86,896 |
0 |
- |
|
CNC |
Centene Corp |
Director |
|
2020-10-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
74,000 |
74,000 |
0 |
- |
|
284 Records found
|
|
Page 11 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|